In the statement, Punjab official Vikas Garg said that the state government had also made approaches regarding the Pfizer, Johnson & Johnson and Sputnik vaccines but has yet to receive any response. "On that basis we may able to supply to states", Agarwal said.
The company maintains its data shows when the vaccine is used in kids 12-17 years of age, there is 93 percent efficacy with one shot and 100 percent after the second dose. "We would have known past year how many doses we needed and what our production capacity was".
Moderna said its vaccine, known as mRNA-1273, was generally well tolerated in trial participants. The Centre neither pursued deals with the USA vaccine makers nor did it invest to scale up domestic production.
Lava destroys homes in DR Congo after volcanic eruption
There was no official word on how many may have been killed amid the scramble to flee the city late Saturday. Power was already cut in large parts of the city when hundreds of residents began leaving their homes.
The Japanese government granted fast-track approval Friday for the coronavirus vaccines developed by US pharmaceutical company Moderna Inc. and Britain's AstraZeneca Plc that are administered in two shots, similar to the vaccine by Pfizer Inc., which was already approved. The vaccination campaign now relies on Covishield from the Serum Institute of India and Covaxin from Bharat Biotech.
Agarwal was responding to questions on what the Centre is doing as as foreign manufacturers including Moderna and Pfizer have refused to sell to the States. "Then, on April 19, they abruptly asked the states to procure vaccines for themselves".
Only about three in 10 parents - 29 percent - of children under 18 said they would get their child vaccinated 'right away'. Moderna had refused Punjab, stating that its policy permits it to deal only with the Government of India. But India is facing a shortage of vaccines, with domestic production amounting to about 80 million doses a month. The current capacity is about 85 million doses per month - 70 million doses of Covishield and 15 million doses of Covaxin.
"With four-and-a-half million COVID-19 vaccine doses delivered before the long weekend, and Canadians continuing to roll up their sleeves as vaccination clinics expand across the country, our fastest moving trend is - happily - our vaccination coverage", said Tam on Tuesday. The remaining third received two doses of placebo.